SlideShare a Scribd company logo
1 of 6
Clostridium Difficile: Prevention,
symptoms, current practice, and
recommendations
Shane Karna, SN
St. Cloud State University
Clostridium Difficile
• Anaerobic gram positive spore forming bacteria
• Signs and Symptoms include:
• 3-15 liquid stools per 24 hr., fever, loss of appetite, fever, nausea, and abdominal
pain/tenderness.
• Transmission
• Fecal-Oral Route including tube feedings
• Factors that increase C. Diff. infection risk
• Patients over the age of 65
• Antibiotics, especially fluoroquinolones, cephalosporins, and clindamycin
• Proton pump inhibitors, H2 blockers
• Patient antibiotic exposure within the last 3 months
• Patient Healthcare setting exposure within the last 3 months
Current Practice
• Hand Hygiene
• Contact Precautions (PPE)
• Room with private bathroom
• Using dedicated equipment or cleaning equipment immediately after use
• Obtaining only fresh liquid stool for sampling
• Educating the patient, family, and care providers on C. Diff.
• Monitoring Electrolytes and serum creatinine
• Discontinuing non-essential medications after a positive diagnosis
(antibiotics, PPIs, and H2 blockers
• Keeping the environment clean
Audit Findings
• Chart audits were performed on four patients who were diagnosed
with C. Diff. four days after their admission
• Nurses followed recommended testing guidelines (3 liquid stools per 24 hr)
• Other C. Diff. symptoms (abdominal pain/tenderness, loss of appetite, fever,
and nausea) were masked by their primary diagnosis or weren’t present until
the fourth day
• One patient was unnecessarily re-tested
• Early C. Diff. recognition wasn’t possible
Recommendations
• Bristol Stool Scale
• Accurate documentation of
frequency and stool characteristics
in EPIC notes.
• Maintain accurate intake and
output
• Do not re-test patients who have
been previously treated for C. Diff.
unless the previous treatment
resulted in a clinical cure
• Disinfecting commonly used
surfaces with bleach
References
• "Health Professional Information on Clostridium Difficile." Minnesota Department of Health.
2015. Retrieved from http://www.health.state.mn.us/divs/idepc/diseases/cdiff/hcp/index.html
• Bor, B. Clostridium Difficile [Powerpoint]
• "Bristol Stool Chart." Continence Foundation of Australia. 2016. Retrieved from
http://www.continence.org.au/pages/bristol-stool-chart.html
• “Clostridium Difficile Infection (CDI) Prevention Strategies 2.0.” Collaborative Healthcare-
Associated Infection Network. Retrieved from
http://www.mnreducinghais.org/documents/HAIGapAnalysisCDI.PDF

More Related Content

What's hot

Periop conference clostridium difficile sep 11 2010
Periop conference   clostridium difficile sep 11 2010Periop conference   clostridium difficile sep 11 2010
Periop conference clostridium difficile sep 11 2010Maureen Spencer, RN, M.Ed.
 
Clostridium Difficile
Clostridium DifficileClostridium Difficile
Clostridium Difficileguest639936c
 
Methicillin resistant staphylococcus aureus
Methicillin resistant staphylococcus aureusMethicillin resistant staphylococcus aureus
Methicillin resistant staphylococcus aureusdaleypeter
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDSadroits
 
Mumps report
Mumps reportMumps report
Mumps reportEdz Gapuz
 
Treating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota TransplantationTreating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota TransplantationEdith Ngobi
 
Intestinal coli infection PPT
Intestinal coli infection PPT Intestinal coli infection PPT
Intestinal coli infection PPT ABHISHEK
 
Pathogenesis i bacterial virulence factors
Pathogenesis i   bacterial virulence factorsPathogenesis i   bacterial virulence factors
Pathogenesis i bacterial virulence factorsTarek Mahbub Khan
 
Mechanism of drug resistance
Mechanism of  drug resistanceMechanism of  drug resistance
Mechanism of drug resistanceDevyashree Medhi
 

What's hot (20)

Periop conference clostridium difficile sep 11 2010
Periop conference   clostridium difficile sep 11 2010Periop conference   clostridium difficile sep 11 2010
Periop conference clostridium difficile sep 11 2010
 
Clostridium Difficile
Clostridium DifficileClostridium Difficile
Clostridium Difficile
 
Clostridium difficile 2010
Clostridium difficile 2010Clostridium difficile 2010
Clostridium difficile 2010
 
Clostridium difficile by Dr.T.V.Rao MD
Clostridium difficile by Dr.T.V.Rao MD Clostridium difficile by Dr.T.V.Rao MD
Clostridium difficile by Dr.T.V.Rao MD
 
Methicillin resistant staphylococcus aureus
Methicillin resistant staphylococcus aureusMethicillin resistant staphylococcus aureus
Methicillin resistant staphylococcus aureus
 
C.diff
C.diffC.diff
C.diff
 
CDI 2019
CDI 2019CDI 2019
CDI 2019
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
Hcv
HcvHcv
Hcv
 
Mumps report
Mumps reportMumps report
Mumps report
 
Treating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota TransplantationTreating Clostridium Difficile Infection With Faecal Microbiota Transplantation
Treating Clostridium Difficile Infection With Faecal Microbiota Transplantation
 
Acinetobacter baumannii an update
Acinetobacter baumannii an update Acinetobacter baumannii an update
Acinetobacter baumannii an update
 
Small pox
Small poxSmall pox
Small pox
 
Intestinal coli infection PPT
Intestinal coli infection PPT Intestinal coli infection PPT
Intestinal coli infection PPT
 
Enteric fever Salmonella infections by Dr.T.V.Rao MD
Enteric feverSalmonella infections by Dr.T.V.Rao MD Enteric feverSalmonella infections by Dr.T.V.Rao MD
Enteric fever Salmonella infections by Dr.T.V.Rao MD
 
Chlamydia
ChlamydiaChlamydia
Chlamydia
 
LSBU C Diff 2016
LSBU C Diff 2016LSBU C Diff 2016
LSBU C Diff 2016
 
Pathogenesis i bacterial virulence factors
Pathogenesis i   bacterial virulence factorsPathogenesis i   bacterial virulence factors
Pathogenesis i bacterial virulence factors
 
Mechanism of drug resistance
Mechanism of  drug resistanceMechanism of  drug resistance
Mechanism of drug resistance
 
Introduction to virology
Introduction to virologyIntroduction to virology
Introduction to virology
 

Viewers also liked

Clostridium difficile infection (cdi)
Clostridium difficile infection (cdi)Clostridium difficile infection (cdi)
Clostridium difficile infection (cdi)Ren Cartago-Luceno
 
Breakthroughs in the Quest to Cure Cancer
Breakthroughs in the Quest to Cure CancerBreakthroughs in the Quest to Cure Cancer
Breakthroughs in the Quest to Cure CancerGerry Potter
 
Rifaximin - Fatro worldwide exclusive antibiotic
Rifaximin - Fatro worldwide exclusive antibioticRifaximin - Fatro worldwide exclusive antibiotic
Rifaximin - Fatro worldwide exclusive antibioticfaroby
 
C. diff presentation
C. diff presentationC. diff presentation
C. diff presentationcallroom
 
Clostridium difficile. Actualización
Clostridium difficile. Actualización Clostridium difficile. Actualización
Clostridium difficile. Actualización lapedrera
 
Clostridium difficile
Clostridium difficileClostridium difficile
Clostridium difficileformaciossibe
 
Rifaximin for Recurrent Clostridium Difficile Infections
Rifaximin for Recurrent Clostridium Difficile InfectionsRifaximin for Recurrent Clostridium Difficile Infections
Rifaximin for Recurrent Clostridium Difficile Infectionslarriva
 

Viewers also liked (9)

News on surveillance of Clostridium difficile infection (CDI), ECCMID 2016
News on surveillance of Clostridium difficile infection (CDI), ECCMID 2016News on surveillance of Clostridium difficile infection (CDI), ECCMID 2016
News on surveillance of Clostridium difficile infection (CDI), ECCMID 2016
 
Clostridium difficile infection (cdi)
Clostridium difficile infection (cdi)Clostridium difficile infection (cdi)
Clostridium difficile infection (cdi)
 
Breakthroughs in the Quest to Cure Cancer
Breakthroughs in the Quest to Cure CancerBreakthroughs in the Quest to Cure Cancer
Breakthroughs in the Quest to Cure Cancer
 
Rifaximin - Fatro worldwide exclusive antibiotic
Rifaximin - Fatro worldwide exclusive antibioticRifaximin - Fatro worldwide exclusive antibiotic
Rifaximin - Fatro worldwide exclusive antibiotic
 
C. diff presentation
C. diff presentationC. diff presentation
C. diff presentation
 
Clostridium difficile. Actualización
Clostridium difficile. Actualización Clostridium difficile. Actualización
Clostridium difficile. Actualización
 
Clostridium
ClostridiumClostridium
Clostridium
 
Clostridium difficile
Clostridium difficileClostridium difficile
Clostridium difficile
 
Rifaximin for Recurrent Clostridium Difficile Infections
Rifaximin for Recurrent Clostridium Difficile InfectionsRifaximin for Recurrent Clostridium Difficile Infections
Rifaximin for Recurrent Clostridium Difficile Infections
 

Similar to Clostridium difficile powerpoint presentation

GASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABS
GASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABSGASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABS
GASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABSMeegsEstabillo2
 
SOAP ON TYPHOID FEVER
SOAP ON  TYPHOID FEVERSOAP ON  TYPHOID FEVER
SOAP ON TYPHOID FEVERSherin John
 
REVISED FOCUSED ANTENATAL CARE (FANC).pptx
REVISED FOCUSED  ANTENATAL  CARE (FANC).pptxREVISED FOCUSED  ANTENATAL  CARE (FANC).pptx
REVISED FOCUSED ANTENATAL CARE (FANC).pptxJustinMutua
 
ANTENATAL CARE by Albert.pptx
ANTENATAL CARE by Albert.pptxANTENATAL CARE by Albert.pptx
ANTENATAL CARE by Albert.pptxTheoJeanTheophile
 
A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)Dr.Emmanuel Godwin
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancerMinati Das
 
Investigation of GI infection outbreak in Nursing Hostel.pptx
Investigation of GI infection outbreak in Nursing Hostel.pptxInvestigation of GI infection outbreak in Nursing Hostel.pptx
Investigation of GI infection outbreak in Nursing Hostel.pptxHarjot Kaur
 
3 ANC FOR C1 by Dr Mekdes.pptx
3 ANC FOR C1 by Dr Mekdes.pptx3 ANC FOR C1 by Dr Mekdes.pptx
3 ANC FOR C1 by Dr Mekdes.pptxBIRHANETESFAY1
 
GROUP 20 PRESENTATION.pptx
GROUP 20 PRESENTATION.pptxGROUP 20 PRESENTATION.pptx
GROUP 20 PRESENTATION.pptxPatrickJames94
 
CAUTI 17 sept final.pptx
CAUTI 17 sept final.pptxCAUTI 17 sept final.pptx
CAUTI 17 sept final.pptxDeepaDevhare2
 
Duodenal Infusion of Donor Feces for Recurrent
Duodenal Infusion of Donor Feces for RecurrentDuodenal Infusion of Donor Feces for Recurrent
Duodenal Infusion of Donor Feces for RecurrentDeborah Armbruster
 
Antenatal assessment
Antenatal assessmentAntenatal assessment
Antenatal assessmentKailash Nagar
 
Antenatal Health Assessment
Antenatal  Health AssessmentAntenatal  Health Assessment
Antenatal Health AssessmentKailash Nagar
 
Dysuria Approach.pdf
Dysuria Approach.pdfDysuria Approach.pdf
Dysuria Approach.pdfSalehAlkhalid
 

Similar to Clostridium difficile powerpoint presentation (20)

GASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABS
GASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABSGASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABS
GASTROINTESTINAL ABDOMINAL ASSESSMENTS AND LABS
 
SOAP ON TYPHOID FEVER
SOAP ON  TYPHOID FEVERSOAP ON  TYPHOID FEVER
SOAP ON TYPHOID FEVER
 
REVISED FOCUSED ANTENATAL CARE (FANC).pptx
REVISED FOCUSED  ANTENATAL  CARE (FANC).pptxREVISED FOCUSED  ANTENATAL  CARE (FANC).pptx
REVISED FOCUSED ANTENATAL CARE (FANC).pptx
 
ANTENATAL CARE by Albert.pptx
ANTENATAL CARE by Albert.pptxANTENATAL CARE by Albert.pptx
ANTENATAL CARE by Albert.pptx
 
A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)A case of acute Pelvic Inflammatory Disease (PID)
A case of acute Pelvic Inflammatory Disease (PID)
 
Colorectal cancer
Colorectal cancerColorectal cancer
Colorectal cancer
 
Investigation of GI infection outbreak in Nursing Hostel.pptx
Investigation of GI infection outbreak in Nursing Hostel.pptxInvestigation of GI infection outbreak in Nursing Hostel.pptx
Investigation of GI infection outbreak in Nursing Hostel.pptx
 
History taking by dr meghanath
History taking by dr meghanathHistory taking by dr meghanath
History taking by dr meghanath
 
3 ANC FOR C1 by Dr Mekdes.pptx
3 ANC FOR C1 by Dr Mekdes.pptx3 ANC FOR C1 by Dr Mekdes.pptx
3 ANC FOR C1 by Dr Mekdes.pptx
 
Fever infants
Fever infantsFever infants
Fever infants
 
GROUP 20 PRESENTATION.pptx
GROUP 20 PRESENTATION.pptxGROUP 20 PRESENTATION.pptx
GROUP 20 PRESENTATION.pptx
 
CAUTI 17 sept final.pptx
CAUTI 17 sept final.pptxCAUTI 17 sept final.pptx
CAUTI 17 sept final.pptx
 
sleeve-gastrec-labs (1).docx
sleeve-gastrec-labs (1).docxsleeve-gastrec-labs (1).docx
sleeve-gastrec-labs (1).docx
 
Antenatal care
Antenatal careAntenatal care
Antenatal care
 
Duodenal Infusion of Donor Feces for Recurrent
Duodenal Infusion of Donor Feces for RecurrentDuodenal Infusion of Donor Feces for Recurrent
Duodenal Infusion of Donor Feces for Recurrent
 
Enhanced Recovery Programme
Enhanced Recovery ProgrammeEnhanced Recovery Programme
Enhanced Recovery Programme
 
Antenatal assessment
Antenatal assessmentAntenatal assessment
Antenatal assessment
 
Antenatal Health Assessment
Antenatal  Health AssessmentAntenatal  Health Assessment
Antenatal Health Assessment
 
Dysuria Approach.pdf
Dysuria Approach.pdfDysuria Approach.pdf
Dysuria Approach.pdf
 
AFI.pdf
AFI.pdfAFI.pdf
AFI.pdf
 

Recently uploaded

Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessSigns It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessGokuldas Hospital
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stocktammysayles9
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTThomas Onyango Kirengo
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?bkling
 
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfBURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfDolisha Warbi
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxYasser Alzainy
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxAkanshaBhatnagar7
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
spinal cord disorders and paraplegia .
spinal cord disorders  and  paraplegia .spinal cord disorders  and  paraplegia .
spinal cord disorders and paraplegia .Mohamed Rizk Khodair
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7grandmotherprocess99
 
Forensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersForensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersAlaguPandi5
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxDr. Rabia Inam Gandapore
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Health Kinesiology Natural Bioenergetics
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...rightmanforbloodline
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxDr. Rabia Inam Gandapore
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialSherrylee83
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024locantocallgirl01
 
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptxclaviclebrown44
 

Recently uploaded (20)

Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing WellnessSigns It’s Time for Physiotherapy Sessions Prioritizing Wellness
Signs It’s Time for Physiotherapy Sessions Prioritizing Wellness
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENTJOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
JOURNAL CLUB PRESENTATION TEMPLATE DOCUMENT
 
Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?Report Back from SGO: What’s the Latest in Ovarian Cancer?
Report Back from SGO: What’s the Latest in Ovarian Cancer?
 
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdfBURNS (CLASSIFICATION & MANAGEMENTS).pdf
BURNS (CLASSIFICATION & MANAGEMENTS).pdf
 
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptxCreeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
Creeping Stroke - Venous thrombosis presenting with pc-stroke.pptx
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
Stereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptxStereochemistry & Asymmetric Synthesis.pptx
Stereochemistry & Asymmetric Synthesis.pptx
 
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose AcademicsCytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
Cytoskeleton and Cell Inclusions - Dr Muhammad Ali Rabbani - Medicose Academics
 
spinal cord disorders and paraplegia .
spinal cord disorders  and  paraplegia .spinal cord disorders  and  paraplegia .
spinal cord disorders and paraplegia .
 
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
High Purity 99% PMK Ethyl Glycidate Powder CAS 28578-16-7
 
Forensic medicine MCQ for early learners
Forensic medicine MCQ for early learnersForensic medicine MCQ for early learners
Forensic medicine MCQ for early learners
 
Face and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptxFace and Muscles of facial expression.pptx
Face and Muscles of facial expression.pptx
 
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
Unlocking Holistic Wellness: Addressing Depression, Mental Well-Being, and St...
 
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
TEST BANK For Porth's Essentials of Pathophysiology, 5th Edition by Tommie L ...
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
 
How to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw materialHow to buy 5cladba precursor raw 5cl-adb-a raw material
How to buy 5cladba precursor raw 5cl-adb-a raw material
 
Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024Top 10 Most Beautiful Russian Pornstars List 2024
Top 10 Most Beautiful Russian Pornstars List 2024
 
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose AcademicsHistology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
Histology of Epithelium - Dr Muhammad Ali Rabbani - Medicose Academics
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 

Clostridium difficile powerpoint presentation

  • 1. Clostridium Difficile: Prevention, symptoms, current practice, and recommendations Shane Karna, SN St. Cloud State University
  • 2. Clostridium Difficile • Anaerobic gram positive spore forming bacteria • Signs and Symptoms include: • 3-15 liquid stools per 24 hr., fever, loss of appetite, fever, nausea, and abdominal pain/tenderness. • Transmission • Fecal-Oral Route including tube feedings • Factors that increase C. Diff. infection risk • Patients over the age of 65 • Antibiotics, especially fluoroquinolones, cephalosporins, and clindamycin • Proton pump inhibitors, H2 blockers • Patient antibiotic exposure within the last 3 months • Patient Healthcare setting exposure within the last 3 months
  • 3. Current Practice • Hand Hygiene • Contact Precautions (PPE) • Room with private bathroom • Using dedicated equipment or cleaning equipment immediately after use • Obtaining only fresh liquid stool for sampling • Educating the patient, family, and care providers on C. Diff. • Monitoring Electrolytes and serum creatinine • Discontinuing non-essential medications after a positive diagnosis (antibiotics, PPIs, and H2 blockers • Keeping the environment clean
  • 4. Audit Findings • Chart audits were performed on four patients who were diagnosed with C. Diff. four days after their admission • Nurses followed recommended testing guidelines (3 liquid stools per 24 hr) • Other C. Diff. symptoms (abdominal pain/tenderness, loss of appetite, fever, and nausea) were masked by their primary diagnosis or weren’t present until the fourth day • One patient was unnecessarily re-tested • Early C. Diff. recognition wasn’t possible
  • 5. Recommendations • Bristol Stool Scale • Accurate documentation of frequency and stool characteristics in EPIC notes. • Maintain accurate intake and output • Do not re-test patients who have been previously treated for C. Diff. unless the previous treatment resulted in a clinical cure • Disinfecting commonly used surfaces with bleach
  • 6. References • "Health Professional Information on Clostridium Difficile." Minnesota Department of Health. 2015. Retrieved from http://www.health.state.mn.us/divs/idepc/diseases/cdiff/hcp/index.html • Bor, B. Clostridium Difficile [Powerpoint] • "Bristol Stool Chart." Continence Foundation of Australia. 2016. Retrieved from http://www.continence.org.au/pages/bristol-stool-chart.html • “Clostridium Difficile Infection (CDI) Prevention Strategies 2.0.” Collaborative Healthcare- Associated Infection Network. Retrieved from http://www.mnreducinghais.org/documents/HAIGapAnalysisCDI.PDF